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VARIABILITY OF CLINICAL AND PRESSURE-FLOW STUDY VARIABLES 
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A BSTRA CT
Purpose; We quantified the physiological variability of clinical and pressure-flow study vari­
ables in patients with symptomatic benign prostatic enlargement. 
Materials and Methods: Symptom scores were measured, and advanced urodynamic studies 
with pressure-flow analysis were performed in 178 patients before and 6 months after a period 
of watchful waiting. 
Results: Patients without bladder outlet obstruction experienced significant symptomatic 
improvement. Symptoms in patients with obvious bladder outlet obstruction did not improve 
significantly. The reproducibility of mean pressure-flow variables was evident. However, there 
was an important intra-individual variability. Patients with obvious bladder outlet obstruction 
showed a significant decrease in detrusor pressure at maximal flow of 14 cm. water, a significant 
decrease in the urethral resistance factor of 7 cm. water and a significant decrease of 1 obstruc­
tion class on the linear passive urethral resistance relation nomogram, indicating less severe 
bladder outlet obstruction. 
Conclusions: Mean differences among therapy groups must be regarded critically, especially 
when the differences are slight and possibly within physiological variability.
Key Words: prostate, prostatic hypertrophy, urodynamics, outcome assessment (health care)
Lower urinary tract symptoms in elderly men are tradi­
tionally labeled prostatism. The term implies cause and rem­
edy, whereas in reality the condition results not only from 
intravesical bladder outlet obstruction caused by the en­
larged prostate but also from motor or sensory abnormalities 
of detrusor and urethral function,1 or even from habit and 
changes in life-style that commonly occur as men age. Pa­
tients and physicians are anxious to know whether the symp­
toms are likely to be progressive and whether there is a risk 
of complications, such as obstructive nephropathy, acute or 
recurrent urinary retention, infection, bleeding, bladder 
stones or other complications that directly affect patient well­
being.
The gold standard for treatment of patients with intracta­
ble urinary retention or obstructive uropathy in the upper 
urinary tract is still transurethral prostatectomy. In the 
past, physicians performed prostatectomy for all patients 
who presented with symptoms. Patients and physicians now 
have a variety of treatment modalities from which to choose. 
Presently, in most situations other factors must be consid­
ered when deciding on appropriate treatment, particularly 
bothersomeness of the voiding disturbances and patient pref­
erences for treatment. A key issue is whether the physician 
should focus on relieving symptoms or obstruction. Unfortu­
nately, lower urinary tract symptoms, prostate size, free 
uroflowmetry parameters and post-void residual urine are 
associated with obstructive voiding but the correlation with 
grade of obstruction is poor.2' 6 Furthermore, subjective effi­
cacy of treatment cannot always be extrapolated to objective 
efficacy.7
A noninvasive treatment approach is watchful waiting. 
More than a third of men with lower urinary tract symptoms
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who remain untreated or are treated with placebo experience 
spontaneous improvement based on subjective criteria, and 
more than 20% improve based on objective criteria.7 This 
spontaneous improvement usually occurs within the first 6 
months if a t all.7 Due to the variable natural history of 
patients with lower urinary tract symptoms, and because 
new treatment modalities do not always result in such dra­
matic subjective and objective effects compared to prostatec­
tomy, inclusion of a control arm that allows quantification of 
these spontaneous effects is becoming increasingly important 
in any trial to evaluate accurately the efficacy of a new 
treatment modality.
Urodynamic investigation is considered to be the gold stan­
dard to quantify grade of bladder outlet obstruction in elderly 
men with lower urinary tract symptoms.8 Precise grading of 
obstruction is becoming increasingly important in the evalu­
ation and comparison of new treatment modalities in pa­
tients with lower urinary tract symptoms and bladder outlet 
obstruction. However, precise grading is relatively sensitive 
to the effect of normal intra-individual variability. Rosier et 
al showed that there is a considerable intra-individual vari­
ability in urodynamic pressure-flow variables when the fill­
ing and voiding sessions during a single urodynamic inves­
tigation are repeated.9 The second voiding session resulted in 
better voiding in a significant number of patients (65%), with 
a lower detrusor pressure at maximum flow rate and a larger 
theoretical urethral area .9
To compare the efficacy of new instrumental and noninva­
sive treatment modalities, and to investigate the reported 
spontaneous subjective and objective improvement after 6 
months without active treatment, we determined the physi­
ological variability of clinical and urodynamic pressure-flow 
study variables in patients with lower urinary tract symp-
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toms and benign prostatic hypertrophy (BPH) who were fol­
lowed with watchful waiting for 6 months.
PATIENTS AND METHODS
In 1992, we initiated a prospective study to evaluate clin­
ical and urodynamic changes in patients with lower urinary 
tract symptoms and BPH in whom watchful waiting was 
chosen. All patients were evaluated at baseline by medical 
history, international prostate symptom score (I-PSS), pros­
tate specific antigen (PSA) analysis, physical examination, 
including digital rectal examination and ultrasonography of 
the prostate, and free uroflowmetry with subsequent u ltra­
sonographic measurement of residual urinary volume. The 
I-PSS consists of 7 questions (total range 0 to 35), 1  of which 
constitutes nocturia score (range 0 to 5). The nocturia score 
indicates the number of times the patient must awaken to 
urinate during the night. A separate question constitutes 
quality of life (range 0 to 6, a greater score indicates worse 
perception of urinary performance). PSA was determined 
with the Hybritech Tandem-E PSA assay.
Prostatic volume was calculated via the planimetric 
method with a Kretz Combison 330 ultrasound scanner with 
a multiplane 3-dimensional rectal transducer. For free uro­
flowmetry the Dantec Urodyn 1000 flowmeter was used. For 
evaluation of voiding efficiency the voided percentage, which 
is the relative amount of bladder contents expelled during 
micturition, was calculated. All patients were considered 
neurologically normal based on history, symptoms and phys­
ical examination (no motor, sensory or reflex deficits). Pa­
tients in whom prostatic carcinoma or other diseases beyond 
the prostate, influencing the lower urinary tract symptoms 
(for example urethral stricture or bladder neck contracture) 
could be expected, as well as those who had received previous 
treatment for lower urinary tract symptoms were excluded 
from the study. After clinical diagnosis of lower urinary tract 
symptoms and BPH, patients were informed about the treat­
ment options. When a urodynamic investigation showed no 
bladder outlet obstruction and the patient experienced rela­
tively few symptoms, or he was not bothered by symptoms 
watchful waiting was recommended besides pharmacological 
treatment or other minimally invasive therapies. On the 
other hand, patients sometimes preferred watchful waiting 
even when bladder outlet obstruction was confirmed. I-PSS 
and urodynamic pressure-flow studies before and after 6 
months of watchful waiting were performed to evaluate 
symptomatic and urodynamic changes. Urinalysis and cul­
ture were negative at the pressure-flow studies.
Urodynamic pressure-flow studies were performed with an 
8F transurethral lumen catheter equipped with an intraves­
ical microtip pressure sensor for bladder pressure recording. 
Abdominal pressure was recorded intrarectally with an 8F 
microtip sensor catheter. Before cystometry, the bladder was 
emptied through the lumen of the transurethral catheter. 
The bladder was filled with water at 20C with a filling speed 
of 50 ml. per minute with the patient supine. Commercially 
available equipment was used to record pressure and flow 
data.
The pressure-flow relationship during voiding was ana­
lyzed by a graph of flow and detrusor pressure, with pressure 
projected on the y axis and flow on the x axis. A pressure-flow 
graph near the y axis, indicating a high pressure that gen­
erates a low flow, is the result of more obstructed voiding 
than a graph near the x axis. Visual evaluation of a pressure- 
flow graph allows for a rough estimation of grade of obstruc­
tion. However, for an objective and quantitative definition of 
the pressure-flow relationship we used the passive urethral 
resistance relation analysis and urethral resistance factor. 
With passive urethral resistance relation analysis, a quad­
ratic curve, the passive urethral resistance relation curve, is 
fitted to the lowest pressure portion of the pressure-flow
graph, which is normally the phase of voiding subsequent to 
maximum flow (fig. l ).10j11 The detrusor pressure at maxi­
mum flow during the urodynamic investigation was re­
corded. The passive urethral resistance relation parameter of 
minimal urethral opening pressure during micturition was 
observed at the end of voiding* The theoretical cross-sectional 
urethral lumen was computed from the slope of the passive 
urethral resistance relation curve.11 A steep curve with a 
slight angle to the pressure axis reflected a narrow urethral 
cross-sectional area. Griffiths et al found a statistical corre­
lation between theoretical cross-sectional urethral lumen 
and minimal urethral opening pressure during voiding.12 
This correlation was used to decrease both parameters to 1 
urethral resistance factor. Urethral resistance factor quanti­
fies obstruction by computing a preset curve with a fixed 
theoretical cross-sectional urethral lumen-to-minimal ure­
thral opening pressure during voiding ratio, through the 
point of detrusor pressure at maximum flow.
The digitally stored pressure and flow data were trans­
lated to a urodynamic analysis computer program developed 
by the research center at our department. This program 
provides a semiautomatic pressure-flow study analysis with 
passive urethral resistance relation and urethral resistance 
factor analysis. The minimal urethral opening pressure dur­
ing voiding and theoretical cross-sectional urethral lumen 
were calculated automatically based on the manually ad­
justed passive urethral resistance relation curves. Correction 
for flow artifacts was performed when necessary. We also 
added a nonparametric analysis of obstruction with clinical 
classes according to the linear passive urethral resistance 
relation pressure-flow nomogram (fig. I ).11 The linear pas­
sive urethral resistance relation was determined by drawing 
a straight line between the detrusor pressure at maximum 
flow and the minimal urethral opening pressure during void­
ing points on the pressure-flow curve. The position of this line 
defined the outlet condition in a simple manner and afforded 
classification of the severity of bladder outlet obstruction. 
Urodynamic variables analyzed included free maximum 
flow rate, free voided volume, residual volume after 
free flowmetry and free voided percentage according to free 
flowmetry, bladder capacity at cystometry, maximum flow at
F ig . 1. Passive urethral resistance relation curves of studied pop­
ulation. Detrusor pressure (cm. water) is projected on y axis and flow 
(ml. per second) is shown on x axis. Indicated are passive urethral 
resistance relation curves based on mean urodynamic values of pa­
tients without (lower quadratic curve), with moderate (middle qua­
dratic curve) and with obvious (upper quadratic curve bladder outlet 
obstruction), Also indicated are 7 linear passive urethral resistance 
relation obstruction classes according to Schäfer et al,11 +, points of 
mean detrusor pressure at maximum flow.
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urodynamic investigation, detrusor pressure at maximum 
flow, minimal urethral opening pressure during voiding, the­
oretical cross-sectional urethral lumen, urethral resistance 
factor, residual volume after uro dynamic pr ess ur e-flow study 
and voided percentage at pressure-flow study according to 
pressure-flow studies. Variables were investigated for the 
entire group of patients and for subgroups categorized with- 
out (linear passive urethral resistance relation class 1  or 
less), with moderate (linear passive urethral resistance rela­
tion class 2 or 3) or with obvious (linear passive urethral 
resistance relation class 4 or more) bladder outlet obstruc­
tion.
Statistical analysis was performed using the Wilcoxon 
matched pairs signed rank test for analysis of numerical data 
and the Krus kal-Wallis 1-way analysis of variance to com­
pare baseline characteristics among groups. The Spearman 
correlation coefficient was calculated to correlate bladder 
capacity and detrusor pressure at maximum flow.
RESULTS
From January 1992 to November 1994, 750 new patients 
with lower urinary tract symptoms and BPH were referred to 
our clinic for evaluation: 17% were treated with transure­
thral thermotherapy, 20% were treated surgically (laser, 
transurethral or open prostatectomy, or bladder neck inci­
sion), 37% received medication (a l blockers or 5a-reductase 
inhibitors), 2% were treated with intermittent or suprapubic 
catheterization, and 24% (178) chose watchful waiting* Four 
of the latter 178 patients were excluded from analysis be­
cause the initial linear passive urethral resistance relation 
category could not be assessed. No pressure-flow study was 
done in 1  patient because he was unable to produce any flow 
at the initial intended voiding. Three patients lost the trans­
urethral (pressure recording) catheter during the initial void­
ing. The baseline characteristics of all 174 patients studied, 
and subgroups without (44%), with moderate (36%) and with 
obvious (20%) bladder outlet obstruction are indicated in 
table 1. In patients with obvious bladder outlet obstruction 
the baseline mean prostatic volume was significantly larger 
(p = 0.02), while mean free voided volume (p = 0.01), free 
maximum flow rate (p < 0.01), bladder capacity (p < 0.01) and 
maximum flow at urodynamic investigation (p < 0.01) were 
significantly smaller, A total of 53 patients was not urody- 
namically evaluable at month 6 because they were lost to 
followup (31), refused the second urodynamic evaluation (19), 
began pharmacological treatment (2) or underwent surgery
(1 ). In figure 2 the initial I-PSS total symptom score and 
initial detrusor pressure at maximum flow, labeled according 
to the reason for dropping out of the study before month 6, 
are plotted for each individual. This scatterplot indicates 
that for these variables patients who were lost to followup or 
who refused the second clinical and pressure-flow study eval­
uation were heterogeneously distributed among those who 
completed watchful waiting for 6 months.
We evaluated 121 patients clinically and uro dynamically 
after 6 months (median 26 weeks, mean 31, range 19 to 116) 
of watchful waiting (fig. 3). Analysis of the pressure-flow 
relationship on the clinical nomogram11 showed that 47% of 
these patients had no, 35% had moderate and 18% had ob­
vious bladder outlet obstruction. Mean urodynamic vari­
ables, and median symptom scores at baseline and after 6 
months of watchful waiting for the 12 1  patients who com­
pleted watchful waiting for 6 months are indicated in table 2, 
as are the percentages of patients with a larger or smaller 
result at the second voiding, At the second free flowmetry, 
59% of the patients voided with a smaller volume and, con­
sequently, 58% voided with a decreased free maximum flow 
rate compared to the first free flowmetry. There was almost 
no difference in mean maximum flow at urodynamic investi­
gation (0.1 ml. per second) but a significant number of pa­
tients (59%) voided with a lower detrusor pressure at maxi­
mum flow rate the second time. Bladder capacity and 
detrusor pressure at maximum flow decreased statistically 
significantly at the second voiding. Calculation with the 
Spearman correlation coefficient showed that there was no 
significant correlation (r = — 0.15, p = 0.10) between bladder 
capacity and detrusor pressure at maximum flow. Further­
more, patients with a smaller voided volume at the second 
urodynamic investigation (59%) had a mean decrease in de­
trusor pressure at maximum flow of 15.2 cm. water, while 
those with a larger voided volume (42%) had a mean decrease 
of 17.1 cm. water. When the theoretical urethral area and 
urethral resistance factor were considered, no significant 
mean differences were shown at the second voiding. A sta­
tistically significant number of patients had improved total 
I-PSS, improved I-PSS nocturia score and improved I-PSS 
quality of life score after 6 months of watchful waiting. How­
ever, mean improvement was clinically not relevant.
Table 3 shows the mean individual absolute differences, 
that is the positive difference resulting from the subtraction 
of both voidings. The mean absolute difference plus or minus 
standard deviation in maximum flow at urodynamic investi-
Table 1. Mean and median (symptom scores and linear passive urethral resistance relation category) baseline characteristics in 174
patientsj and for subgj^oups withoutt with moderate and with obvious bladder outlet obstruction
Linear Passive Urethral Resistance Relation
0 and 1 (77 pts.) 2 and 3 (63 pts.) 4 to 6 (34 pts.) 0 to 6 (174 pts.)
Mean age ± SD (yrs.) 65 ± 8 63 ± 8 65 ± 8 64 ± 8
Mean PSA ± SD (ng./ml.) 2.5 ± 2.2 2.7 ± 2.3 4.7 ± 5.5 3.0 ± 3.3
Mean prostate vol. ± SD (cc) 37 ± 13 37 ± 14 49 ± 22* 39 ± 16
I-PSS (range):
Total 13 (1-31) I S (2-28) 13 (2-33) 13 (1-33)
Nocturia 2 (0-5) 2 (0-5) 2 (0-5) 2 (0-5)
Quality of life 4 (0-6) 3.5 (0-6) 3 (1-5) 3 (0-6)
Mean free voided vol. ±  SD (ml.) 324 ± 169 336 ± 204 230 ± 108* 310 ± 176
Mean free maximum flow rate ± SD (ml./sec.) 14.0 ± 5.8 13.2 ± 4.9 10.0 ± 3.8* 12.9 ± 5.3
Mean free residual vol. ± SD (ml.) 39 ± 59 53 ± 73 63 i  82 49 ± 70
Mean free voided % ± SD 89 ± 15 86 ± 17 82 ± 18* 87 ± 16
Mean bladder capacity ± SD (ml.) 467 ± 132 470 ± 125 383 ± 96* 451 ± 127
Mean maximum flow at urodynamic study ± SD (ml./sec.) 10.6 ± 4.2 8.3 ± 2.8 6.5 ± 3.2* 8.9 ± 3.9
Mean residual vol. after urodynamic study ± SD (ml.) 39 ± 74 62 ± 87 80 ± 102 54 ± 85
Mean voided % at pressure-flow study ± SD 92 ± 15 87 ± 18 80 ± 24 88 ± 18
Mean detrusor pressure at maximum flow ± SD (cm. water) 31.0 ± 12.2 54.9 ± 12.7 87.9 ± 20.8* 50.9 ± 25.6
Mean minimum urethral opening pressure ± SD (cm. water) 14.4 ± 7.2 26.3 ±  9.7 43.8 ± 21.7* 24.6 ± 16.3
Mean theoretical cross-sectional urethral lumen ± SD (mm.2) 6.21 ± 3.08 3.63 ±  1.27 2.23 ± 0.96* 4.50 ± 2.74
Mean urethral resistance factor ± SD (cm. water) 18.5 ± 10.4 30.6 ± 6.0 50.2 ± 10.6* 29.1 ± 14.9
Linear passive urethral resistance relation (range)
.  / ' I  4 . a  . 4  «  «  •  i  a  j  ^  ^  ~  «  m * M ^
1 (0-1) 2 (2-3) 4 (4-6)* 2 (0-6)
* Statistically significant difference (p <0.05) in baseline characteristics among 3 groups without, with moderate and with obvious bladder outlet obstruction.
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gation between both voidings was 2.3 ± 2.1 ml. per second. 
Values of extreme, large and small differences are shown in 
this table, as well as the number of patients exceeding these 
differences. In 50 patients (42%) the difference in maximum 
flow at urodynamic investigation between both voidings was 
more than 2.0 ml. per second and in 36 (30%) there were only 
slight differences (less than 1 ml. per second). Mean maxi­
mum flow at urodynamic investigation in patients with ex­
treme differences did not change significantly. In the entire 
group mean maximum flow at urodynamic investigation was
8.9 ±3.8 ml. per second initially and 8.8 ±  3.7 ml. per second 
at the second study. In the group with extreme differences 
mean maximum flow at urodynamic investigation was 8.9 ±
3.9 ml. per second initially and 9.4 ± 3.8 ml. per second a t the 
second study. When evaluating patients with extreme differ­
ences of detrusor pressure at maximum flow, it appeared
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Table 2. Mean and median (symptom  scores and linear passive urethral resistance relation category) variables at baseline and after
6 months of watchful waiting in 121 patients who completed the second urodynamic evaluation
Baseline Mo. 6
Wilcoxon 
p Value 
(baseline vs. mo. 6)
°/o Second Voiding
Larger Smaller
Free voided vol. (ml.) 314 257 0.005* 40 59
Free maximum flow rate (ml./sec.) 13.2 12.1 0.028!,: 38 58
Free residual vol. (ml.) 48 34 0.207 37 44
Free voided % 87 89 0.931 42 43
Bladder capacity (ml.) 460 435 0.019* 41 59
Maximum flow at urodynamic study (ml./sec.) 8.9 8.8 0.286 57 38
Residual vol. after urodynamic study (ml,) 58 46 0.157 25 38
Voided % at pressure-flow study 87 90 0.104 38 23
Detrusor pressure at maximum flow (cm water) 50.6 46.9 0.023:,: 41 59
Minimum urethral opening pressure (cm. water) 24.1 21.3 0.103 40 58
Theoretical cross-sectional urethral lumen (mm,2) 4.34 4.38 0.965 48 52
Urethral resistance factor (cm. water) 28.2 26.9 0.349 44 51
Linear passive urethral resistance relation (range) 
I-PSS (range);
2 (0—5) 2 (0-4) 0.296 27 35
Total 13 (1-33) 11 (1-30) <0.001* 33 64
Nocturia 2 (0-5) 1 (0-5) 0,004* 13 34
Quality of life 3 (0-6) 2 (0-6) <0.001* 6 51
* Statistically significant difference (p <0.05).
Table S. Mean individual absolute differences in symptoms and urodynamic results} and number of patients with clinically extreme,
clinically large and slight differences among 121 who completed the second clinical and urodynamic pressure-flow study
Mean Absolute 
Difference ± SD
Extreme Differences Large Differences Slight Differences
Value No. Pts, (%) Value No. Pts. (%) Value No. Pts, {%)
Free voided vol. (ml.) 142 ± 131 More than  200 22 (20) More th an  100 60 (56) Less than 50 25 (23)
Free maximum flow rate (mL/sec.) 3.5 ± 3.1 More than 2.8 54 (50) More th an  2 62 (57) Less than 1 23 (21)
Free residual vol. (ml.) 40 ± 54 More than  200 2 (2) More th an  100 12(11) Less than 50 78 (74)
Bladder capacity (ml.) 75 ± 65 More than 200 5 (4) More than  100 36 (30) Less than 50 53 (45)
Maximum flow at urodynamic study (ml./sec,) 2.3 ± 2.1 More than 2.8 34 (29) More than  2 50 (42) Less than 1 36 (30)
Residual vol. after urodynamic study (ml.) 63 ± 87 More than  200 9 (8) More than  100 26 (24) Less than 50 66 (61)
Detrusor pressure at maximum flow (cm. water) 15.6 ± 14.8 More than  27 15 (13) More than  15 47 (40) Less than 5 29 (25)
Minimum urethral opening pressure (cm. water) 10.9 ± 9.8 More than 34 4 (4) More th an  15 21 (19) Less than 5 24 (22)
Theoretical cross-sectional urethral lumen (mm.2) 1.46 ± 1,39 More than  2.3 26 (22) More th an  15 41 (35) Less than 5 30 (26)
Urethral resistance factor (cm. water) 7.6 ± 6,1 More than  18 8 (7) More than  15 14 (12) Less than 5 41 (35)
Total I-PSS 5.3 ± 3.9 More than 18 1 (1) More than  10 10(11) Less than 5 47 (53)
that they had either an extreme small or an extreme large 
detrusor pressure at maximum flow at the initial voiding. 
Patients with extreme differences in theoretical cross- 
sectional urethral lumen were mainly those with an extreme 
large theoretical cross-sectional urethral lumen at the initial 
voiding. When we performed the statistical analysis without 
the patients with extreme values as indicated in table 3 the 
mean results remained unchanged, indicating that extreme 
differences in the entire group of patients occurred at the 
same magnitude in the negative and positive directions.
In table 4, the clinical and urodynamic parameters at base­
line and after 6 months of watchful waiting are shown for 12 1  
patients, grouped by linear passive urethral resistance rela­
tion. In patients without bladder outlet obstruction total 
I-PSS, I-PSS nocturia score and I-PSS quality of life score 
improved significantly. These improvements were slight and 
clinically not relevant. In the group with moderate bladder 
outlet obstruction the improvements in total I-PSS, I-PSS 
nocturia score and I-PSS quality of life score were also sta­
tistically significant but clinically irrelevant. In the group 
with obvious bladder outlet obstruction a significant im­
provement in total I-PSS, I-PSS nocturia score and I-PSS 
quality of life score could not be shown. Mean free voided 
volume and free maximum flow rate were decreased at the 
second voiding but the differences were not statistically sig­
nificant in the 3 groups. Compared to the first result, the 
second mean detrusor pressure at maximum flow was 5.2 cm. 
water larger (p = 0.18) in the group without bladder outlet 
obstruction, 9.7 cm. water smaller (p <0.01) in the group 
with moderate obstruction and 14.1 cm. water smaller (p = 
0.01) in the group with obvious bladder outlet obstruction. 
When patients with extreme differences in detrusor pressure
at maximum flow (table 3) were excluded, the differences in 
mean detrusor pressure at maximum flow were not signifi­
cant, The second mean detrusor pressure at maximum flow 
in the group without bladder outlet obstruction was then 1.7 
cm. water larger (p = 0.46) and in the group with moderate 
obstruction it was 9.0 cm. water smaller (p <0.01), while in 
the group with obvious bladder outlet obstruction the second 
mean detrusor pressure at maximum flow was 5.6 cm. water 
smaller (p = 0.1 1 ).
Compared to the first result, the second mean minimal 
urethral opening pressure during voiding and urethral resis­
tance factor were 0.5 and 2.8 cm. water larger in the group 
without bladder outlet obstruction (p = 0.99 and p = 0.02, 
respectively), and 4.9 and 3.1 cm. water smaller in the group 
with moderate bladder outlet obstruction (p = 0.03 and p = 
0.08, respectively). In the group with obvious bladder outlet 
obstruction the second mean minimal urethral opening pres­
sure during voiding and urethral resistance factor were 5.1 
and 7.0 cm. water smaller (p -  0.52 and p ~ 0.02, respec­
tively). Mean theoretical cross-sectional urethral lumen did 
not change significantly. The second mean theoretical cross- 
sectional urethral lumen was 0.35 mm.2 smaller in the group 
without bladder outlet obstruction (p = 0.23), 0.47 mm .2 
larger in the group with moderate obstruction (p = 0.29) and 
0.24 mm .2 larger in the group with obvious bladder outlet 
obstruction (p = 0.14). Although the median linear passive 
urethral resistance relation in the group without bladder 
outlet obstruction remained unchanged (class 1 ) the second 
linear passive urethral resistance relation category was 
larger in 22 patients, smaller in 10 and unchanged in 22. 
This difference was statistically significant (p = 0.01). In the 
group with moderate bladder outlet obstruction the median
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Table 4. Mean and median (symptom scores and linear passive urethral resistance relation classification) variables a t  baseline and after
6 months of watchful waiting in 121 patients who completed the second urodynamic evaluation
Linear Passive Urethral Resistance Relation
0 and 1 (57 pts.) 2 and 3 (42 pts.) 4 to 6 (22 pts.)
Baseline Mo. 6 Baseline Mo. 6 Baseline Mo. 6
Pt. age (yrs.) 66 62 64
Prostate vol. (cc) 37 37 45
I-PSS (range):
Total 12 (1-31) 10 (1-26)* 14 (3-28) 10.5 (3-24)* 13 (6-33) 12.5 (3-30)
Nocturia 2 (0-5) 1 (0-4)* 2 (0-5) 1 (0-4) 2 (1-5) 2 (1-5)
Quality of life 3 (0-6) 2 (0-6)* 3 (0-6) 2 (0-5)* 4 (2-5) 2 (0-5)
Free voided vol. (ml.) 331 272 334 271 237 182
Free maximum flow rate (ml./sec.) 14.2 12.8 13.4 12.3 10.0 9.6
Free residual vol. (ml.) 40 25 46 42 62 31
Free voided % 90 92 86 87 83 86
Bladder capacity (ml.) 481 470 468 438 390 347*
Maximum flow at urodynamic study (mlVsec,) 10.1 9.8 8.8 8.8 6.0 6.2
Residual vol. after urodynamic study (ml.) 43 40 57 60 93 36*
Voided % at pressure-flow study 91 92 88 87 77 90*
Detrusor pressure at maximum flow (cm. water) 32.7 37.9 55.8 46.1* 86.4 72.3*
Minimum urethral opening pressure (cm. water) 15.1 15.6 26.6 21.7* 40.8 35.7
Theoretical cross-sectional urethral lumen (mm.2) 5.57 5.22 3.85 4,32 2.06 2,30
Urethral resistance factor (cm. water) 18.1 20.9* 29.6 26.5 51.4 44.4*
Linear passive urethral resistance relation (range) 1 (0-1) 1 (0-3)* 2 (2-3) 2 (0-4) 4 (4-5) 3 (2-4)*
* Statistically significant difference (p <0.05) comparing results a t  baseline versus month 6.
linear passive urethral resistance relation classification re­
mained unchanged (class 2). The second linear passive ure­
thral resistance relation category in these patients was 
greater in 10, smaller in 18 and the same in 13 (p = 0.05), In 
the group with obvious bladder outlet obstruction the median 
linear passive urethral resistance relation changed from 4 
;e 4 to 5) to 3 (range 2 to 4), which was significant. Of 
these patients 14 had a smaller linear passive urethral re­
sistance relation at the second voiding, 7 remained un­
changed and none had a larger value (p < 0*01),
After evaluation at month 6, 102 patients (84%) contin­
ued watchful waiting, 9 began pharmacological treatm ent, 
4 underwent transurethral microwave thermotherapy and 
6 underwent surgery. Thereafter, 66 patients were fol­
lowed for a median of 31.4 weeks (range 1 to 97), during 
which time 2 underwent surgery and 2 began pharmaco­
logical treatment. In figure 4 the initial detrusor pressure 
at maximum flow and total I-PSS are indicated for each 
individual, with a followup of longer than 6 months, la­
beled according to the last treatm ent policy: surgery in 9, 
transurethral thermotherapy in 4, pharmacological trea t­
ment in  16 and watchful waiting in 114. This figure indi­
cates that all patients who underwent surgery or who 
received transurethral thermotherapy had a large 
initial detrusor pressure a t maximum flow (all but 
1 had an initial detrusor pressure at maximum flow of 
more than 55 cm. water), and tha t patients who received 
pharmacological treatm ent had a small initial detrusor 
pressure at maximum flow (all but 1 had an initial detru­
sor pressure at maximum flow of less than  55 cm. water). 
Initial total I-PSS values were heterogeneously distributed 
among the different treatm ent options.
a surgery
*  TUMT
A pharmacoi. treatment
* watchful waiting
F ig . 4. Scatterplot indicates initial detrusor pressure at maximum flow (cm. water) on y axis and total I-PSS on x axis for all patients with 
followup longer than 6 months, according to last treatment of watchful waiting, pharmacological (pharmacol.) therapy, transurethral 
thermotherapy (TUMT) or surgery.
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DISCUSSION
Urodynamic investigation with pressure-flow study and 
symptom scores enabled us to investigate the relationship 
between objective and subjective efficacy of treatment. Pre­
viously, when the therapeutic choice was limited to surgery 
or watchful waiting, pressure-flow evaluation was simply 
used to diagnose bladder outlet obstruction. Because new, 
less invasive treatment modalities are now available, precise 
grading of obstruction is increasingly important in the eval­
uation of treatment efficacy.13 The clinical nomogram used in 
our study has 7 obstruction categories, and is more detailed 
than a diagnosis of obstruction or no obstruction.11 Pressure- 
flow evaluation is able to provide a continuous numeric scale 
of obstruction and, therefore, is even more refined. Further­
more, stratification of therapeutic options based on the indi­
vidual, accurately assessed, grade of obstruction has recently 
become available.14»15 For a reliable assessment of grade of 
obstruction on a numeric scale, it is essential tha t the test 
result is accurate and reproducible. The accuracy and repro­
ducibility of a test can be determined by repeating it directly 
after the test has been done, and by repeating it at different 
times or with different equipment depending on the circum­
stances. Rosier et al showed that the test result of pressure- 
flow studies is reproducible, with only slight variability when 
the filling and voiding session during a single urodynamic 
pressure-flow study is repeated.9 We studied the intra­
individual variability of the test results of symptom scores 
and pressure-flow studies when the test was repeated after 6 
months without treatment.
When evaluating the total investigated group of patients 
and comparing our results with those of Rosier et al,9 the 
mean changes in detrusor pressure at maximum flow, max­
imum flow at urodynamic investigation and urethral resis­
tance factor were comparable. In the study of Rosier et al 63% 
of the patients voided the second time with a smaller detru­
sor pressure at maximum flow, and the mean difference of
3.0 cm. water was statistically significant.9 In our study 59% 
of patients voided the second time with a smaller detrusor 
pressure at maximum flow, and the mean difference of 3.7 
cm. water was statistically significant. However, the mean 
difference in theoretical cross-sectional urethral lumen in the 
study of Rosier et al was 0.36 mm.2, which was statistically 
significantly larger the second time,9 while in our study there 
was only an insignificant difference of 0.04 mm.2.
Regarding the variations of pressure-flow study variables 
in our study, the percentages of patients with extreme or 
large differences of urodynamic pressure-flow study vari­
ables was greater but the mean pressure-flow study variables 
were not relevantly different (table 3). However, there was a 
statistically significantly smaller detrusor pressure at max­
imum flow and bladder capacity at the second evaluation 
(table 2). However, the magnitude of the changes in detrusor 
pressure at maximum flow and bladder capacity was slight 
and the clinical relevance must be questioned. A smaller 
bladder capacity may theoretically result in decreased pres­
sure at micturition with a smaller detrusor pressure at max­
imum flow. Therefore, we calculated the Spearman correla­
tion coefficient in our patients. There appeared to be no 
significant correlation (r = -0.15, p — 0.10) between bladder 
capacity and detrusor pressure at maximum flow. Further­
more, 62 patients with a smaller voided volume at the second 
urodynamic investigation had a mean decrease in detrusor 
pressure at maximum flow of 15.2 cm. water, while those 
with a larger voided volume at the second urodynamic inves­
tigation had a mean decrease of 17.1 cm. water. This finding 
indicates that in our study it is not likely that a smaller 
bladder capacity is the important factor resulting in a de­
creased detrusor pressure at maximum flow.
Rosier et al studied relatively more patients with an in­
creased grade of bladder outlet obstruction and, therefore, we
must be cautious when drawing conclusions from a compar­
ison of, in essence, 2 different populations.9 The greater vari­
ability found in our study could be due to the variations in the 
dynamic component as described by Caine.16 Caine sug­
gested that a combination of mechanical and dynamic com­
ponents has a significant impact on lower urinary tract 
symptoms. The mechanical component, that is the enlarged 
prostate gland, does not spontaneously decrease with time.17 
In contrast, the dynamic component is subject to rapid 
changes depending on a variety of factors that influence 
sympathetic activity. Among these factors, stress, cold and 
use of sympathomimetic agents can increase clinical symp­
toms, indicating that these dynamic components probably 
involve the smooth muscle tone in the prostate, prostate 
capsule and bladder neck.16-18 With a longer interval be­
tween investigations the dynamic component may have a 
greater impact on the differences between the test results.
The values at baseline confirm that patients with obvious 
bladder outlet obstruction have decreased maximal flow 
rates. In our study patients with obvious bladder outlet ob­
struction also had significantly decreased free voided vol­
umes and a significantly smaller bladder capacity. In the 
obvious bladder outlet obstruction group a free voided vol­
ume of 230 ± 108 ml. indicates that, although they are 
instructed to present to the outpatient clinic with a full 
bladder, a considerable percentage of patients have an initial 
voided volume of less than 150 ml., which is a cutoff point 
frequently used as a selection criterion in clinical trials. 
Evidently, some patients with obvious bladder outlet obstruc­
tion do not enter these trials, while the largest urodynamic 
treatment responses are reported in those with low maximal 
flow rates .19 Consequently, the study results may not be 
linearly extrapolated to the population. In fact, clinical trials 
in patients with a free voided volume of 150 ml. or more may 
underestimate the urodynamic treatment responses that 
could be detected in the population.
At the second free flowmetry study 59% of the patients 
voided with a smaller volume and, consequently, 58% voided 
with a decreased free maximum flow rate compared to the 
first study. When comparing the free voided volumes with 
free maximum flow rate using the Liverpool nomograms, it 
appeared that the values of the first voiding, that is voided 
volume 314 ml. and free maximum flow rate 13.2 ml. per 
second, correspond with the 7th percentile, while the values 
of the second voiding, that is voided volume 257 ml, and free 
maximum flow rate 12 .1  ml. per second, correspond with the 
8th percentile of the healthy men investigated.20 This finding 
indicates that the changes in flow rates were merely a result 
of changes in voided volumes.
The pro static volume in patients with obvious bladder out­
let obstruction was significantly larger, confirming the sta­
tistically significant although moderate correlation between 
prostate size and bladder outlet obstruction.5-6
After 6 months of watchful waiting, total I-PSS was signif­
icantly less in 64% of the patients, I-PSS nocturia score was 
significantly less in 34% and I-PSS quality of life score 
was significantly less in 51%, confirming that subjective dif­
ferences do not always correlate with objective differences in 
urodynamic variables.7 In patients without bladder outlet 
obstruction all subjective tests were statistically significantly 
improved after 6 months of watchful waiting. In patients 
with moderate bladder outlet obstruction only total I-PSS 
and I-PSS nocturia score were statistically significantly 
improved. One may argue that the subjective difference after
6 months of watchful waiting in patients without and with 
moderate bladder outlet obstruction was statistically signif­
icant but clinically irrelevant, although it is remarkable 
that in those with obvious obstruction no subjective improve­
ment was shown. There was not even a tendency for im­
provement in total I-PSS and I-PSS nocturia score. This 
finding confirms the results of the Veterans Affairs Cooper­
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ative Study on transurethral resection of the prostate versus 
watchful waiting.21 In this study the symptomatic patients 
were randomized for either watchful waiting or surgery. In 
the watchful waiting group 30 to 40% of the patients showed 
symptomatic improvement. This group may, in fact, be pa­
tients without bladder outlet obstruction (44% of our 
patients). The authors concluded that watchful waiting is 
usually a safe alternative for men who are less bothered by 
urinary difficulty or who wish to delay surgery. We agree 
with their conclusion because we have shown th a t in pa­
tients with obvious bladder outlet obstruction symptoms 
may not improve but certainly they do not worsen. More­
over, the urodynamic status after 6 months of watchful 
waiting in patients with obvious bladder outlet obstruction 
does not seem to worsen. However, the long-lasting urody­
namic effect in patients with obvious bladder outlet ob­
struction is still uncertain. Hopefully, we will be able to 
extend our study and to repeat the investigations in some 
patients who remained on watchful waiting to evaluate the 
natural history of lower urinary tract symptoms and BPH 
with or without bladder outlet obstruction. However, with 
time more patients will be lost to followup or treated as 
shown in figure 4.
At our center, patients with a large initial detrusor pres­
sure at maximum flow were treated with transurethral ther­
motherapy or surgery, while those with a low initial detrusor 
pressure at maximum flow were treated pharmacologically. 
The initial symptom scores were heterogeneously distributed 
among the different treatment options. Apparently, for the 
physicians at our center the results of pressure-flow studies 
rather than symptom scores have an important role in  deter­
mining choice of therapy (fig. 4).
The changes in mean pressure-flow variables among the 3 
linear passive urethral resistance relation groups were re­
markably different. Patients without bladder outlet obstruc­
tion had changes indicating more obstruction, while those 
with bladder outlet obstruction initially had less obstruction. 
The increases of mean urethral resistance factor and mean 
linear passive urethral resistance relation in patients with­
out bladder outlet obstruction were slight but statistically 
significant. The decreases in mean detrusor pressure at max­
imum flow and mean minimal urethral opening pressure 
during voiding in patients with moderate bladder outlet ob­
struction were significant, and the decreases in mean detru­
sor pressure at maximum flow, urethral resistance factor and 
linear passive urethral resistance relation in patients with 
obvious bladder outlet obstruction were significant. Even 
mean residual volume and mean voided percentage at 
pressure-flow study improved significantly in patients with 
obvious bladder outlet obstruction. The difference in mean 
detrusor pressure at maximum flow in patients with obvious 
obstruction was 14.1 cm. water, which comes close to the 
suggested clinically relevant cutoff point for differences in 
pressure classes of 15 cm. water.9 These findings could be 
explained by regression towards the mean, a statistical phe­
nomenon in which, if a followup sample is chosen based on 
extreme scores, the retest scores will tend to be closer to the 
population mean than the initial scores. As suggested by 
Caine,16 numerous varying factors may influence the dy­
namic part of the obstruction, and these factors may occa­
sionally combine to produce a result that is either extremely 
large or extremely small. When measurements are repeated, 
it is unlikely that components that involve a random element 
should combine again in this extreme fashion. Large values 
accordingly tend to decrease, while small values tend to 
increase. Just as these extreme values tend to regress to the 
population mean on reexamination, patients with chronic but 
fluctuating conditions tend to seek medical attention in the 
"bad” periods during exacerbations. Consequently, the condi­
tion is more prone to improve than to deteriorate further 
regardless of the treatment instituted.
We compared the previously reported urodynamic trea t­
ment efficacy of new instrumental and noninvasive therapies 
to the physiological variability reported in our study. After 
laser prostatectomy, an individual mean improvement in 
detrusor pressure at maximum flow of 37 cm. water was 
reported.22 This result is unequivocal and larger than the 
expected physiological variability. After transrectal high in­
tensity focused ultrasound and transurethral thermotherapy 
of the prostate, statistically significant improvements in 
mean detrusor pressure at maximum flow of 1 1  and 10 cm. 
water have been reported.23-24 Based on our results, these 
findings could be obtained simply by repeating the urody­
namic pressure-flow evaluation after 6 months without ther­
apy. Tammela and Kontturi reported a mean decrease in 
detrusor pressure at maximum flow of 39 cm. water after 
finasteride treatment for 6 months and a mean increase in 
detrusor pressure at maximum flow of 3 cm. water in the 
placebo group, indicating a significant response to trea t­
ment.25 The results of this study conflict with our results. 
Considering the large mean detrusor pressure at maximum 
flow in the study by Tammela and Kontturi (120 cm. water), 
the majority of the patients studied had severe bladder outlet 
obstruction, and we would also expect a decrease in detrusor 
pressure at maximum flow in the placebo group.25 The uro­
dynamic response in a study evaluating the efficacy of dox­
azosin, an a l  selective blocker, although significantly better 
compared to placebo treatment, was slight (improvement in 
detrusor pressure at maximum flow 5 cm. water) and within 
physiological variability.26 These findings indicate that mean 
differences among therapy groups must be regarded criti­
cally) particularly when the reported differences are slight 
and possibly within physiological variability. The variability 
of pressure-flow parameters in our study was greater than in 
a previous study when the filling and voiding session was 
repeated during a single urodynamic pressure-flow evalua­
tion. However, mean pressure-flow parameters were only 
slightly different. This finding indicates that the dynamic 
component of obstruction actually exists and should be con­
sidered in the evaluation of new treatment modalities for 
patients with lower urinary tract symptoms and BPH.
CONCLUSIONS
We demonstrated tha t patients without bladder outlet ob­
struction experienced statistically significant but slight 
symptomatic improvement after 6 months of watchful w ait­
ing. Symptoms of patients with obvious bladder outlet ob­
struction did not improve significantly. From a clinical and 
diagnostic viewpoint, the reproducibility of mean pressure- 
flow study results after 6 months of watchful waiting was 
evident. However, there was an important intra-individual 
variability. Patients with extreme values at the initial 
pressure-flow study tended to experience regression towards 
the mean of the population at the second evaluation. Patients 
with obvious bladder outlet obstruction showed a significant 
decrease in detrusor pressure at maximum flow of 14 cm. 
water, a significant decrease in urethral resistance factor of
7 cm, water and a significant decrease of 1 obstruction class 
on the linear passive urethral resistance relation nomogram, 
indicating less severe bladder outlet obstruction. Mean dif­
ferences among therapy groups m ust be regarded critically, 
particularly when the reported differences are slight and 
possibly within physiological variability. Due to the physio­
logical variability caused by the dynamic component of ob­
struction, any clinical trial evaluating a new treatment mo­
dality should include a control arm th a t allows quantification 
of this physiological variability.
Hanny Derks-Boes and Anke Gerrits performed data col­
lection and processing.
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EDITORIAL COMMENT
It is not surprising to receive important reports on the urodynam- 
ics and pathophysiology of BPH from our European colleagues. This 
study is uniquely important because it provides such thorough symp­
tomatic and urodynamic data on the short-term natural history of 
obstruction with BPH. This information will be valuable, particu­
larly as the authors continue to follow these patients with similar 
evaluations into the future. Appropriately, the authors remembered 
to correlate the statistical and clinical significance of the data. They 
demonstrate several key clinical correlations. Urodynamically and 
symptomatically, BPH is a dynamic process. Where the patient is 
today may not be where he will be tomorrow. Importantly, even 
patients with severe obstruction on urodynamics will not predictably 
worsen in the short term, and will more likely improve. Even in that 
patient group watchful waiting does not imply either neglect or 
acquiescence to an inevitable deterioration. The authors again 
showed us that all patients with symptoms of BPH do not have 
urodynamic obstruction (44% of their patients are in this group), and 
that severity of symptoms and obstruction do not correlate. Also, we 
must be cautious when making BPH treatment recommendations 
based on a single test done in 1 day. This is not to say that symptom 
scores and urodynamic studies are not potentially usefuhbut only 
that they must always be placed in perspective with the complete 
picture.
In the near future it would be interesting if the authors would 
present data on a few specific patient subgroups. For example, what 
are the urodynamic results and outcomes specifically for those with 
symptom scores greater than 7? (There were an unknown number 
with scores less than 7 who underwent urodynamic studies, some­
thing that does not occur often in the United States.) Do patients 
with symptom scores that do not change in the short term ultimately 
have more severe obstruction and a worse prognosis? How does the 
obstruction group with watchful waiting compare in ultimate out­
comes with treated patients instead? (After all, the authors recom­
mended treatment for many patients with urodynamic obstruction.) 
Did their careful evaluation of these patients produce a symptomatic 
placebo benefit for some, particularly those with more severe ob­
struction?
Regardless of whether the authors answer these questions, other 
careful studies such as this will provide a more thorough under­
standing of the urodynamic characteristics of BPH, For that reason 
the authors are to be thanked. In the longer term, it will be inter­
esting to follow the symptoms and urodynamics of this cohort of 
patients.
Richard F. Labasky
Division of Urology
University of Utah School of Medicine
Salt Lake City, Utah
